CAUSEY CHRISTOPHER bought UTHR

July 24, 2025 · Form 4 insider transaction

CAUSEY CHRISTOPHER bought 3,650 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction

Acquired (buy-side)

3,650

Price

$0.00

Total value

N/A

InsiderCAUSEY CHRISTOPHER

RoleDirector

CompanyUnited Therapeutics Corporation (UTHR)

SecurityStock Options

Transaction codeA — Grant or award

Transaction dateJuly 24, 2025

Filing dateJuly 28, 2025

Shares owned after3,650

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Annual non-employee director award.

View the original Form 4 on SEC EDGAR